Publicaciones en las que colabora con JUDIT PALLARES QUIXAL (10)
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543
-
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma
Human Pathology, Vol. 42, Núm. 2, pp. 185-193
2010
-
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850
2009
-
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma
Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226
-
CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation
American Journal of Pathology, Vol. 174, Núm. 1, pp. 287-296
-
Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints
Journal of Clinical Pathology, Vol. 62, Núm. 9, pp. 777-785
2008
-
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells
Oncogene, Vol. 27, Núm. 18, pp. 2513-2524
-
Loss of heterozygosity in endometrial carcinoma
International Journal of Gynecological Pathology, Vol. 27, Núm. 3, pp. 305-317
-
Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma
Human Pathology, Vol. 39, Núm. 7, pp. 994-1001
-
Targeted therapies in gynecologic cancers and melanoma
Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273